Related Posts
- Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial
Background Up to 20% of patients with non-small cell lung cancer (NSCLC) develop brain metastasis…
- Neoadjuvant Nivolumab Shows Promising Outcomes In Non-metastatic ccRCC
KEY TAKEAWAYS The phase 1 study investigated the impact of PD-1 inhibitors on immune cells…
- Cabozantinib Plus Nivolumab Shows Promise in Non-clear-Cell Renal Cell Carcinoma
KEY TAKEAWAYS A phase 2 clinical trial (CA209-9KU) with cabozantinib and nivolumab was conducted in…